Peptides in Skincare: What Topical Studies Report

Peptides have become one of the most discussed ingredient families in cosmetic formulation literature. This page summarises, in third person, what published studies and reviews have reported about peptides applied to skin, how authors describe their proposed mechanisms, where the evidence is strongest, and where reviewers themselves identified gaps. This page is for educational purposes only and is not medical advice; consult a licensed physician about any skin or medical concern.

What Peptides Are in a Skincare Context

Peptides are short chains of amino acids — shorter than full proteins — linked by peptide bonds. In cosmetic science writing, the term usually refers to synthetic or hydrolysis-derived fragments whose sequences resemble parts of larger skin proteins such as collagen or elastin, or resemble fragments generated when those proteins break down. A 2025 review of bioactive peptides in cosmetic formulations surveyed the current in vitro and ex vivo evidence base for these ingredients and grouped them by proposed activity rather than by marketing category (PMID 40946970).

A related ingredient class is hydrolyzed collagen: a 2019 review described its sources, production by enzymatic hydrolysis, and applications across food, biomedical and cosmetic sectors, noting that hydrolysis produces mixtures of peptides of varying molecular weight rather than a single defined molecule (PMID 31703345). That distinction matters when comparing studies, because "collagen peptides" in one paper may not be the same material as in another.

How Peptides Are Described to Work on Skin

Reviews of the field generally describe four proposed mechanism groups. These are mechanistic frameworks drawn from laboratory work, not confirmed outcomes in consumers.

Signal peptides

A 2021 review of signal peptides in cosmetics described this group as sequences that interact with cells of the dermis and are studied for their reported ability to influence extracellular matrix protein synthesis, including collagen, and to modulate pathways associated with skin ageing (PMID 34382523). A 2025 review of peptides as candidates in skin senescence described overlapping mechanisms, including antioxidant activity and effects on matrix-degrading enzyme pathways reported in preclinical models (PMID 39858482).

Carrier peptides

The best-documented example is GHK (glycyl-L-histidyl-L-lysine), which binds copper. A 2015 review characterised GHK as a naturally occurring tripeptide reported to modulate multiple cellular pathways involved in skin regeneration, including wound repair, antioxidant responses and gene expression relevant to extracellular matrix remodelling (PMID 26236730).

Neurotransmitter-inhibiting peptides

A 2002 report introduced the synthetic hexapeptide known as Argireline and described its proposed interference with neurotransmitter release at the neuromuscular junction, with researchers reporting reduced wrinkle depth in facial measurements after topical application of a 10% solution over 30 days (PMID 18498523). That report remains the reference point most often cited for this mechanism class.

Enzyme-inhibiting and matrix-protective peptides

The 2025 senescence review grouped additional sequences by their reported inhibition of enzymes that degrade dermal matrix components and by antioxidant activity observed in cell and tissue models (PMID 39858482). A 2024 review focused specifically on collagen in photoaged skin and discussed how ultraviolet exposure alters collagen structure and turnover, which is the biological problem most cosmetic peptide research aims at (PMID 38009842).

Peptide Categories at a Glance

What Topical Studies Report

The topical evidence base is uneven. The largest volume of data sits in cell culture and excised-skin models: the 2025 formulation review compiled in vitro and ex vivo findings for cosmetic peptides and noted that translation from these models to finished products applied on intact skin is not automatic (PMID 40946970).

GHK illustrates the gap between mechanism and delivery. A 2025 paper examining topically applied GHK as an anti-wrinkle peptide discussed its advantages alongside explicit problems, including limited penetration through the stratum corneum and formulation stability, and framed delivery strategies as prospective rather than settled (PMID 39963574). The earlier GHK review had already noted that much of the supporting work came from wound-healing and cell-signalling models rather than cosmetic endpoints (PMID 26236730).

For signal peptides, the 2021 review described them as promising ingredients while noting that published cosmetic studies were frequently small and heterogeneous in design (PMID 34382523). The Argireline report remains one of the few older topical papers with a stated concentration and duration, with the study describing a 10% solution used over 30 days (PMID 18498523).

Why penetration is the recurring question

Peptides are hydrophilic and relatively large compared with classic small-molecule actives, and reviewers repeatedly identified skin barrier passage as the limiting step; the 2025 GHK paper devoted attention to this problem and to carrier approaches under investigation (PMID 39963574). The cosmetic formulation review reached a similar conclusion, reporting that measured activity in an ex vivo model does not establish equivalent activity from a marketed formulation (PMID 40946970).

Topical Versus Ingested Peptides: Two Separate Evidence Bases

Much of the clinical trial literature people associate with "skin peptides" actually tested oral collagen peptides, not creams. A 2014 randomized study in women aged 35–55 reported that daily intake of 2.5 g or 5 g of specific bioactive collagen peptides for 8 weeks reduced eye wrinkle volume compared with placebo, with researchers also reporting increased procollagen type I and elastin content in a subgroup analysis (PMID 24401291).

A 2015 paper combined an ex vivo skin model with randomized, placebo-controlled clinical work and reported improvements in skin moisture and changes in the dermal collagen network after oral collagen peptide supplementation for 8 weeks (PMID 26362110). A 2018 randomized, double-blind, placebo-controlled study of low-molecular-weight collagen peptide reported improvements in skin hydration, elasticity and wrinkling over 12 weeks of daily intake (PMID 29949889), and a 2024 randomized, double-blinded, placebo-controlled study of a low-molecular-weight collagen peptide supplement reported outcomes the authors described as promoting healthy skin (PMID 37822045).

These are ingestion studies. Their outcomes cannot be transferred to a topical product containing a differently sized or differently sequenced peptide, and the reviews on cosmetic formulation treated the two routes separately (PMID 40946970).

Peptides and the Lips: What the Literature Covers

Among the papers summarised here, none tested a peptide in a lip balm or reported lip-specific endpoints. Lip skin differs from facial skin in barrier thickness and in the absence of substantial sebaceous coverage, which is why reviewers' general caution about penetration and stability applies with no lip-specific data to refine it (PMID 39963574). Questions about peptides in lip products therefore sit outside the published scope of the studies reviewed on this page, and the 2025 cosmetic formulation review similarly reported that most available data came from facial-skin or skin-model systems (PMID 40946970).

Safety and Tolerability on Skin: What Studies Report

The verified literature summarised here reported comparatively little in the way of adverse events, which reflects both the nature of the studies and their small size rather than an established safety conclusion. The 2002 Argireline report described topical application of a 10% solution over 30 days without reporting tolerability problems as a principal finding (PMID 18498523). Reviews of signal peptides in cosmetics discussed these ingredients as generally well tolerated in cosmetic use while noting the limitations of the underlying studies (PMID 34382523).

For ingested collagen peptides, the randomized studies reported their outcomes without describing serious adverse events as a headline finding, including the 12-week low-molecular-weight collagen peptide trial (PMID 29949889) and the 8-week bioactive collagen peptide trial (PMID 24401291). Several reviewers emphasised that short study durations, small sample sizes and cosmetic rather than clinical endpoints limit what can be concluded about long-term safety (PMID 39858482). Individual sensitivities, fragrance and preservative systems, and copper-containing complexes are formulation-level questions that the peptide literature alone does not answer, and dermatological evaluation is the appropriate route for anyone with a skin condition.

How the Categories Are Taught and Discussed

Esthetics and cosmetology coursework, trade publications and peer-reviewed reviews tend to use the same four-way split described above — signal, carrier, neurotransmitter-inhibiting and enzyme-inhibiting — because it maps onto the mechanisms authors proposed. The 2021 signal-peptide review and the 2025 senescence review both organised their discussion along mechanistic lines of this kind (PMID 34382523, PMID 39858482). The categories are descriptive conveniences: a single sequence can plausibly belong to more than one group, and the review literature does not treat category membership as evidence of effect.

Reading Peptide Skincare Claims Critically

• Check the route. Wrinkle and hydration outcomes reported in the collagen literature came from oral supplementation over 8 to 12 weeks, not from creams (PMID 24401291, PMID 29949889).
• Check the model. Much cosmetic peptide data came from in vitro and ex vivo systems, as the 2025 formulation review reported (PMID 40946970).
• Check delivery. Reviewers identified penetration and stability as open problems for topical GHK specifically (PMID 39963574).
• Check the material. "Collagen peptides" describes heterogeneous hydrolysates rather than one defined ingredient (PMID 31703345).
• Check the biology being targeted. Photoaging involves structural change to collagen described in the 2024 review, which is a broader process than any single ingredient addresses (PMID 38009842).

Summary of the Evidence Picture

Across the papers summarised here, researchers described plausible mechanisms and a growing preclinical literature, a small number of older topical reports with stated concentrations and durations, and a more substantial set of randomized trials that tested ingested collagen peptides rather than topical ones. Reviewers were consistent that delivery through the skin barrier remains the central unresolved question for topical peptides (PMID 39963574, PMID 40946970). This page is educational and does not recommend or discourage any product; questions about individual skin should be directed to a licensed physician or dermatologist.

References

• Hydrolyzed Collagen-Sources and Applications (Molecules, 2019)
• Collagen study advances for photoaging skin (Photodermatology, Photoimmunology & Photomedicine, 2024)
• Signal Peptides - Promising Ingredients in Cosmetics (Current Protein & Peptide Science, 2021)
• GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (BioMed Research International, 2015)
• Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis (Skin Pharmacology and Physiology, 2014)
• Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study (Nutrients, 2018)
• Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective (BioImpacts, 2025)
• Low-molecular-weight collagen peptides supplement promotes a healthy skin: A randomized, double-blinded, placebo-controlled study (Journal of Cosmetic Dermatology, 2024)
• Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review (Biomolecules, 2025)
• The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network (Journal of Cosmetic Dermatology, 2015)
• Bioactive peptides in cosmetic formulations: Review of current in vitro and ex vivo evidence (Peptides, 2025)
• A synthetic hexapeptide (Argireline) with antiwrinkle activity (International Journal of Cosmetic Science, 2002)